Pacira Biosciences Inc

NASDAQ:PCRXUnited States

Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. EXPAREL is used across multiple orthopedic procedures, including joint reconstruction, shoulder, spine, extremity procedures, and hip fractures. It is developing interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain. Its clinical development programs include PCRX-201, and pMVL-Based Clinical Program.

Contact Information

Headquarters

5401 West Kennedy Boulevard, Suite 890TAMPA, FL, United States 33609

Phone

813-553-6680

Fax

302-655-5049

Executives

Independent Chairman of the Board

Paul Hastings

Chief Executive Officer, Director

Frank Lee

Chief Financial Officer

Shawn Cross

Chief Operating Officer

Daryl Gaugler

Interim Chief Financial Officer

Lauren Riker